FindTrial
Sign In

Genetic loci for Skin Fluorescence in type 1 Diabetes Mellitus

Genetic loci for Skin Fluorescence in type 1 Diabetes Mellitus - Genetic loci for SF

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42373
Enrollment
350
Registered
2017-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

identificeren van SNPs die geassocieerd zijn met huid fluorescentie single nucleotide polymorphism snip

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Signed informed consent Type 1 DM Age * 18 years

Exclusion criteria

Exclusion criteria: Subjects who lack mental capacity to make their own decision / subjects who have a legal-guardian for ongoing medical decisions (including but not limited to mental retardation, schizophrenia, bi-polar disorder, degenerative cognitive decline). ;Participant in life-line study.

Design outcomes

Primary

MeasureTime frame
The primary outcome variable for the Genomic-Wide Association Study (GWAS) will be Skin Auto Fluorescence (SAF).—

Secondary

MeasureTime frame
Association of SNPs with HbA1c—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)